Imaging of the pial arterial vasculature of the human brain in vivo using high-resolution 7T time-of-flight angiography
Abstract
The pial arterial vasculature of the human brain is the only blood supply to the neocortex, but quantitative data on the morphology and topology of these mesoscopic arteries (diameter 50-300µm) remains scarce. Because it is commonly assumed that blood flow velocities in these vessels are prohibitively slow, non-invasive time-of-flight MRI angiography (TOF-MRA)-which is well-suited to high 3D imaging resolutions-has not been applied to imaging the pial arteries. Here, we provide a theoretical framework that outlines how TOF-MRA can visualize small pial arteries in vivo, by employing extremely small voxels at the size of individual vessels. We then provide evidence for this theory by imaging the pial arteries at 140-µm isotropic resolution using a 7T MRI scanner and prospective motion correction, and show that pial arteries one voxel-width in diameter can be detected. We conclude that imaging pial arteries is not limited by slow blood flow, but instead by achievable image resolution. This study represents the first targeted, comprehensive account of imaging pial arteries in vivo in the human brain. This ultra-high-resolution angiography will enable the characterization of pial vascular anatomy across the brain to investigate patterns of blood supply and relationships between vascular and functional architecture.
Data availability
The anonymized imaging data presented in this manuscript are stored in OSF (OSF, Center for Open Science, Inc., Charlottesville, Virginia, USA) accessible via https://osf.io/nr6gc/.
Article and author information
Author details
Funding
National Institute of Biomedical Imaging and Bioengineering (P41-EB015896)
- Jonathan R Polimeni
National Institutes of Health (S10-RR019371)
- Jonathan R Polimeni
National Institutes of Health (S10-OD02363701)
- Jonathan R Polimeni
European Commission (MS-fMRI-QSM 794298)
- Simon D Robinson
National Institute of Biomedical Imaging and Bioengineering (P41-EB030006)
- Jonathan R Polimeni
National Institute of Biomedical Imaging and Bioengineering (R01-EB019437)
- Jonathan R Polimeni
National Institute of Neurological Disorders and Stroke (R21-NS106706)
- Jonathan R Polimeni
National Institute of Mental Health (R01-MH111438)
- Saskia Bollmann
National Institute of Mental Health (R01-MH111419)
- Saskia Bollmann
Natural Sciences and Engineering Research Council of Canada
- Michaël Bernier
Fonds de recherche du Québec – Nature et technologies
- Michaël Bernier
Deutsche Forschungsgemeinschaft (MA 9235/1-1)
- Hendrik Mattern
- Oliver Speck
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: Four healthy adults volunteered to participate in the study (four males, ages 30-46). Prior to imaging, written informed consent was obtained from the three participants scanned in Boston (Figure 5, 6, 8 and 9 and corresponding figure supplements) in accordance with the Partners Human Research Committee and the Massachusetts General Hospital Institutional Review Board (protocol #2016P000274); after the study completion, a consent form addendum was used to obtain informed consent from each participant specifically to share their anonymized data on a public data repository. For the single subject from Magdeburg (Figure 7 and corresponding figure supplements) the consent to share openly the data in anonymized form was acquired prospectively (facultative option in study consent form) in accordance with the 'Ethikkommission Otto-von-Guericke-Universität Magdeburg' (protocol 15/20).
Copyright
© 2022, Bollmann et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,615
- views
-
- 624
- downloads
-
- 42
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Neuroscience
Synchronous neuronal activity is organized into neuronal oscillations with various frequency and time domains across different brain areas and brain states. For example, hippocampal theta, gamma, and sharp wave oscillations are critical for memory formation and communication between hippocampal subareas and the cortex. In this study, we investigated the neuronal activity of the dentate gyrus (DG) with optical imaging tools during sleep-wake cycles in mice. We found that the activity of major glutamatergic cell populations in the DG is organized into infraslow oscillations (0.01–0.03 Hz) during NREM sleep. Although the DG is considered a sparsely active network during wakefulness, we found that 50% of granule cells and about 25% of mossy cells exhibit increased activity during NREM sleep, compared to that during wakefulness. Further experiments revealed that the infraslow oscillation in the DG was correlated with rhythmic serotonin release during sleep, which oscillates at the same frequency but in an opposite phase. Genetic manipulation of 5-HT receptors revealed that this neuromodulatory regulation is mediated by Htr1a receptors and the knockdown of these receptors leads to memory impairment. Together, our results provide novel mechanistic insights into how the 5-HT system can influence hippocampal activity patterns during sleep.
-
- Neuroscience
The classical diagnosis of Parkinsonism is based on motor symptoms that are the consequence of nigrostriatal pathway dysfunction and reduced dopaminergic output. However, a decade prior to the emergence of motor issues, patients frequently experience non-motor symptoms, such as a reduced sense of smell (hyposmia). The cellular and molecular bases for these early defects remain enigmatic. To explore this, we developed a new collection of five fruit fly models of familial Parkinsonism and conducted single-cell RNA sequencing on young brains of these models. Interestingly, cholinergic projection neurons are the most vulnerable cells, and genes associated with presynaptic function are the most deregulated. Additional single nucleus sequencing of three specific brain regions of Parkinson’s disease patients confirms these findings. Indeed, the disturbances lead to early synaptic dysfunction, notably affecting cholinergic olfactory projection neurons crucial for olfactory function in flies. Correcting these defects specifically in olfactory cholinergic interneurons in flies or inducing cholinergic signaling in Parkinson mutant human induced dopaminergic neurons in vitro using nicotine, both rescue age-dependent dopaminergic neuron decline. Hence, our research uncovers that one of the earliest indicators of disease in five different models of familial Parkinsonism is synaptic dysfunction in higher-order cholinergic projection neurons and this contributes to the development of hyposmia. Furthermore, the shared pathways of synaptic failure in these cholinergic neurons ultimately contribute to dopaminergic dysfunction later in life.